13D Filing: Spitcaufsky Larry and Chanticleer Holdings Inc. (HOTR)

Page 4 of 5 – SEC Filing

SCHEDULE 13D/A Amendment No. 2
This Amendment No. 2 to Schedule 13D amends the statements by Larry Spitcaufsky (the “Reporting Person” or “Mr. Spitcaufsky”) on Schedule 13D filed on June 30, 2017 (the “Initial Statement”), as amended by Amendment No. 1 filed on August 9, 2017 (“Amendment No. 1” and together with the Initial Statement, the “Amended Statement”). The Amended Statement shall not be modified except as specifically provided herein.
Item 1.
Security and Issuer.
No changes to this Item.
Item 2.
Identity and Background.
Item 2(c) of the Amended Statement is hereby amended to add the following paragraph:
(c)
Mr. Spitcaufsky also currently serves as a member of the board of directors of the Issuer.
Item 3.
Source and Amount of Funds or Other Consideration.
No changes to this Item.
Item 4.
Purpose of Transaction.
No changes to this Item.
Item 5.
Interest in Securities of the Issuer.
No changes to this Item.
Item 6.
Contracts, Arrangements, Understandings or Relationships With Respect to Securities of the Issuer.
No changes to this Item.
Item 7.
Material to be Filed as Exhibits.
No changes to this Item.

Follow Sonnet Biotherapeutics Holdings Inc. (NASDAQ:SONN)